Du Jianhang, Zhou Ying, Bao Xiaogang, Kang Zhanrong, Huang Jianming, Xu Guohua, Yi Chengqing, Li Dejian
Department of Orthopedics, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.
Department of Rehabilitation, General Hospital of Chinese People's Liberation Army, Beijing, China.
Front Bioeng Biotechnol. 2022 Jul 22;10:974533. doi: 10.3389/fbioe.2022.974533. eCollection 2022.
Bone defects are a common challenge for clinical orthopedic surgeons. The existing bone defect repair materials are difficult to achieve satisfactory osseointegration between the material and the bone. Therefore, it is increasingly important to find effective methods to improve the integration of the materials with the bone and thus facilitate bone defect repair. Researchers have found that polydopamine (PDA) has a structure and properties similar to the adhesive proteins secreted by mussels in nature, with good biocompatibility, bioactivity, hydrophilicity, bio-adhesion and thermal stability. PDA is therefore expected to be used as a surface modification material for bone repair materials to improve the bonding of bone repair materials to the bone surface. This paper reviews research related to PDA-modified bone repair materials and looks at their future applications.
骨缺损是临床骨科医生面临的常见挑战。现有的骨缺损修复材料难以在材料与骨之间实现令人满意的骨整合。因此,找到有效的方法来改善材料与骨的整合从而促进骨缺损修复变得越来越重要。研究人员发现,聚多巴胺(PDA)具有与自然界中贻贝分泌的粘附蛋白相似的结构和特性,具有良好的生物相容性、生物活性、亲水性、生物粘附性和热稳定性。因此,PDA有望用作骨修复材料的表面改性材料,以改善骨修复材料与骨表面的结合。本文综述了与PDA改性骨修复材料相关的研究,并探讨了它们的未来应用。